Department of Nephrology1 and Department of Surgery,2 Erasmus Medical Center, Rotterdam, and Department of Nephrology,3 Albert Schweitzer Hospital, Dordrecht, Netherlands.
Perit Dial Int. 2013 Sep-Oct;33(5):503-6. doi: 10.3747/pdi.2012.00105. Epub 2013 Jun 3.
Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis (PD). It is characterized by encapsulation of the bowel, causing symptoms of intestinal obstruction. Exclusive involvement of parts of the bowel may occur and may be more common than previously thought. Our main objective was to investigate and report on patients with localized EPS.
Between July 2002 and December 2011, 9 of 17 EPS patients were referred to our department of surgery for a diagnostic laparotomy. Three of the 9 cases showed localized encapsulation of the small bowel and were selected for the purpose of this study.
All 3 patients presented with an acute inflammatory state and symptoms of bowel obstruction. In 2 patients, EPS became clinically overt after kidney transplantation; the third patient was diagnosed while on hemodialysis. All shared a history of PD ranging from 31 to 101 months. In none of the patients was radiologic examination conclusive, although 2 showed peritoneal thickening and ascites. Each patient underwent laparotomy, confirming EPS. In all cases, a thickened peritoneal membrane became apparent, predominantly covering the ileocecal region of the intestine. In addition, a constrictive membrane at the level of the terminal ileum was noted. In 2 cases, the patients underwent enterolysis and dissection of the constricting fibrotic peritoneal membrane (peritonectomy) without bowel resection. The 3rd patient was managed with parenteral nutrition and tamoxifen. The postoperative course in 1 patient was complicated by infected ascites that resolved with antibiotic treatment. Eventually, all patients were doing well, with adequate oral intake and without the need for repeat surgery.
Localized EPS may be more common than previously thought. It has a predilection for the level of the terminal ileum. We believe that an elective diagnostic laparotomy should be considered early, because this procedure offers both diagnostic opportunities and therapeutic options. Localized EPS cases may benefit most from enterolysis and peritonectomy.
包裹性腹膜硬化症(EPS)是腹膜透析(PD)的一种罕见并发症。其特征为肠被包裹,导致肠梗阻症状。肠的部分区域可能会出现局限性累及,且可能比之前认为的更为常见。我们的主要目的是调查和报告局限性 EPS 患者。
2002 年 7 月至 2011 年 12 月期间,在我们外科系的 17 名 EPS 患者中,有 9 名因疑似诊断而接受剖腹探查术。这 9 例中有 3 例表现为小肠局限性包裹,因此被选入本研究。
所有 3 名患者均表现出急性炎症状态和肠梗阻症状。2 例在肾移植后 EPS 才表现出临床症状,第 3 例则在血液透析时被诊断。所有患者 PD 病史均为 31 至 101 个月。尽管有 2 例显示腹膜增厚和腹水,但没有任何影像学检查具有确诊意义。所有患者均接受剖腹探查术,以明确 EPS 诊断。所有病例均显示腹膜明显增厚,主要累及回盲部。此外,还注意到末端回肠水平存在约束性膜。在 2 例中,患者接受肠松解术和约束性纤维腹膜切除术(腹膜切除术),而无需肠切除术。第 3 例患者则接受肠外营养和他莫昔芬治疗。1 例患者术后出现感染性腹水,经抗生素治疗后得到缓解。最终,所有患者均恢复良好,能够正常口服摄入,无需再次手术。
局限性 EPS 可能比之前认为的更为常见。它倾向于发生在末端回肠水平。我们认为,应尽早考虑进行选择性诊断性剖腹探查术,因为该手术既能提供诊断机会,又能提供治疗选择。局限性 EPS 患者最适合接受肠松解术和腹膜切除术。